tradingkey.logo

SelectQuote Inc

SLQT
1.100USD
+0.070+6.80%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
193.90MValor de mercado
10.13P/L TTM

Mais detalhes de SelectQuote Inc Empresa

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises the SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expense, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

Informações de SelectQuote Inc

Código da empresaSLQT
Nome da EmpresaSelectQuote Inc
Data de listagemMay 21, 2020
CEODanker (Timothy Robert)
Número de funcionários1181
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 21
Endereço6800 West 115Th Street
CidadeOVERLAND PARK
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal66211
Telefone19132741994
Sitehttps://ir.selectquote.com/investor-home/default.aspx
Código da empresaSLQT
Data de listagemMay 21, 2020
CEODanker (Timothy Robert)

Executivos da empresa SelectQuote Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
371.21K
+52631.00%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
363.21K
+52631.00%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
--
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+44106.00%
Mr. Donald L. Hawks, III
Mr. Donald L. Hawks, III
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Earl H. (Trace) Devanny, III
Mr. Earl H. (Trace) Devanny, III
Independent Director
Independent Director
--
--
Mr. Raymond F. Weldon
Mr. Raymond F. Weldon
Independent Director
Independent Director
--
--
Mr. William Thomas Grant, III
Mr. William Thomas Grant, III
Chief Operating Officer
Chief Operating Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
371.21K
+52631.00%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
363.21K
+52631.00%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
--
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+44106.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Pharmacy revenue
218.54M
66.46%
Commission
94.97M
28.88%
Production bonus and other revenue
15.30M
4.65%
Por RegiãoUSD
Nome
Receita
Proporção
United States
328.81M
100.00%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Pharmacy revenue
218.54M
66.46%
Commission
94.97M
28.88%
Production bonus and other revenue
15.30M
4.65%

Distribuição de ações

Atualizado em: seg, 17 de nov
Atualizado em: seg, 17 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Brookside Equity Partners LLC
10.03%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.59%
Abrams Bison Investments, L.L.C.
4.49%
Mariner Wealth Advisors
3.61%
Outro
72.17%
Investidores
Investidores
Proporção
Brookside Equity Partners LLC
10.03%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.59%
Abrams Bison Investments, L.L.C.
4.49%
Mariner Wealth Advisors
3.61%
Outro
72.17%
Tipos de investidores
Investidores
Proporção
Investment Advisor
20.37%
Investment Advisor/Hedge Fund
12.09%
Individual Investor
11.43%
Private Equity
10.03%
Hedge Fund
8.15%
Research Firm
2.10%
Corporation
0.62%
Pension Fund
0.28%
Bank and Trust
0.21%
Outro
34.72%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
334
93.80M
53.31%
-7.75M
2025Q3
327
94.38M
53.63%
-3.32M
2025Q2
332
110.44M
63.96%
+4.81M

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Brookside Equity Partners LLC
17.68M
10.05%
--
--
Sep 20, 2025
BlackRock Institutional Trust Company, N.A.
9.01M
5.12%
-200.07K
-2.17%
Sep 30, 2025
The Vanguard Group, Inc.
8.19M
4.65%
-20.74K
-0.25%
Sep 30, 2025
Abrams Bison Investments, L.L.C.
7.91M
4.5%
--
--
Sep 30, 2025
Mariner Wealth Advisors
6.37M
3.62%
+3.06K
+0.05%
Sep 30, 2025
Grant (William Thomas II)
4.66M
2.65%
+94.89K
+2.08%
Nov 12, 2024
Grant (Robert Clay)
4.32M
2.45%
--
--
Sep 20, 2025
Grant (William Thomas III)
4.20M
2.39%
--
--
Sep 20, 2025
Geode Capital Management, L.L.C.
3.33M
1.89%
+29.89K
+0.91%
Sep 30, 2025
State Street Investment Management (US)
2.96M
1.68%
-139.64K
-4.50%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: ter, 2 de dez
Atualizado em: ter, 2 de dez
Nome
Proporção
iShares Micro-Cap ETF
0.06%
Fidelity Enhanced Small Cap ETF
0.04%
WisdomTree US SmallCap Quality Growth Fund
0.04%
Avantis US Small Cap Equity ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
Avantis US Small Cap Value ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Ver Mais
iShares Micro-Cap ETF
Proporção0.06%
Fidelity Enhanced Small Cap ETF
Proporção0.04%
WisdomTree US SmallCap Quality Growth Fund
Proporção0.04%
Avantis US Small Cap Equity ETF
Proporção0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0.02%
ProShares Hedge Replication ETF
Proporção0.01%
iShares Russell 2000 ETF
Proporção0.01%
Avantis US Small Cap Value ETF
Proporção0.01%
Schwab U.S. Small-Cap ETF
Proporção0.01%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI